05:00
2026-08-27
innolitics.com
ai-policy
The De Novo Pays the Toll: How Sample Size Shrinks Across AI Device Generations
A new analysis of 1,483 FDA AI/ML device records finds that follow-on 510(k) clearances for AI medical devices require dramatically fewer new patients than the original De Novo authorizations, with di…